Pfizer Inc Drug Patent Portfolio
Pfizer Inc owns 3 orange book drugs protected by 9 US patents Given below is the list of Pfizer Inc's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6794370 | Method for treating cancer using camptothecin derivatives and 5-fluorouracil | 01 Nov, 2020 | Expired |
| US6403569 | Method for treating cancer using camptothecin derivatives and 5-fluorouracil | 28 Oct, 2020 | Expired |
| US7175855 | Ziprasidone suspension | 18 May, 2020 | Expired |
| US6794370 | Method for treating cancer using camptothecin derivatives and 5-fluorouracil | 01 May, 2020 | Expired |
| US6403569 | Method for treating cancer using camptothecin derivatives and 5-fluorouracil | 28 Apr, 2020 | Expired |
| US6150366 | Ziprasidone formulations | 27 May, 2019 | Expired |
| US6245766 | Method of treating psychiatric conditions | 18 Dec, 2018 | Expired |
| US5656255 | Composition to help stop smoking | 12 Aug, 2014 | Expired |
| US5312925 | Monohydrate of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one-hydrochloride | 01 Sep, 2012 | Expired |
Latest Legal Activities on Pfizer Inc's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Pfizer Inc.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Email Notification
Critical
| 09 Nov, 2016 | US6794370 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 09 Nov, 2016 | US6794370 |
|
Correspondence Address Change
Critical
| 08 Nov, 2016 | US6794370 |
|
Correspondence Address Change
Critical
| 29 Aug, 2014 | US6794370 |
|
Recordation of Patent Grant Mailed
Critical
| 21 Sep, 2004 | US6794370 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 21 Sep, 2004 | US6794370 |
|
Issue Notification Mailed
Critical
| 02 Sep, 2004 | US6794370 |
| Receipt into Pubs | 27 Aug, 2004 | US6794370 |
| Dispatch to FDC | 25 Aug, 2004 | US6794370 |
|
Application Is Considered Ready for Issue
Critical
| 25 Aug, 2004 | US6794370 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 15 Jul, 2004 | US6794370 |
|
Correspondence Address Change
Critical
| 14 Jul, 2004 | US6794370 |
|
Issue Fee Payment Received
Critical
| 04 Jun, 2004 | US6794370 |
|
Issue Fee Payment Verified
Critical
| 04 Jun, 2004 | US6794370 |
| Workflow - File Sent to Contractor | 28 Apr, 2004 | US6794370 |
Pfizer Inc's Family Patents
Pfizer Inc Drug List
Given below is the complete list of Pfizer Inc's drugs and the patents protecting them.
1. Camptosar
Camptosar is protected by 4 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6794370
(Pediatric)
| Method for treating cancer using camptothecin derivatives and 5-fluorouracil |
01 Nov, 2020
(4 years ago)
| Expired |
| US6403569
(Pediatric)
| Method for treating cancer using camptothecin derivatives and 5-fluorouracil |
28 Oct, 2020
(4 years ago)
| Expired |
| US6794370 | Method for treating cancer using camptothecin derivatives and 5-fluorouracil |
01 May, 2020
(4 years ago)
| Expired |
| US6403569 | Method for treating cancer using camptothecin derivatives and 5-fluorouracil |
28 Apr, 2020
(4 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Camptosar's drug page
2. Geodon
Geodon is protected by 4 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7175855 | Ziprasidone suspension |
18 May, 2020
(4 years ago)
| Expired |
| US6150366 | Ziprasidone formulations |
27 May, 2019
(5 years ago)
| Expired |
| US6245766 | Method of treating psychiatric conditions |
18 Dec, 2018
(6 years ago)
| Expired |
| US5312925 | Monohydrate of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one-hydrochloride |
01 Sep, 2012
(12 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Geodon's drug page
3. Nicotrol
Nicotrol is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5656255 | Composition to help stop smoking |
12 Aug, 2014
(10 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Nicotrol's drug page